Omar Ali, Visiting Lecturer, VBA & Former Advisor, NICE, University of Portsmouth, will be joining the speaker faculty at the 2025 Market Access, Pricing and Reimbursement Global Congress Europe (MAPR Europe).
As European healthcare systems face mounting pressure to balance access to innovative treatments with financial sustainability, the congress brings together industry leaders to explore the future of market access, HTA, pricing, and reimbursement strategies. With rising healthcare costs, evolving payer frameworks, and the growing complexity of therapeutic innovations like cell and gene therapies, MAPR 2025 offers a timely platform for sharing insights, best practices, and forward-looking solutions.
Can We Afford a Cure? Paying for Innovation
DAY TWO: Wednesday, April 30 - 9:10am
Omar will deliver a keynote exploring some of the toughest questions facing global market access today, including:
Geopolitical pressures and access challenges for high-cost medicines
Pharma’s alignment on value—and the barriers to demonstrating compelling value propositions
Real-world applications of value-based agreements and innovative contracting from global markets
Access and reimbursement models for combo oncology, multiple indications, and cell and gene therapies
The full MAPR 2025 agenda will focus on “Comprehensive Strategies and Embracing Innovations to Overcome Barriers in Patient Access,” bringing together expert speakers from across the healthcare and life sciences sectors.
We look forward to joining the discussion—and connecting with colleagues and partners across the industry—at MAPR 2025.
Omar Ali
Visiting Lecturer, VBA & Former Advisor, NICE,
University of Portsmouth
About Omar Ali
More Info & Registration
More information and registration directly via the MAPR2025 Conference website…